Deutsch wins creative rights for V-Go's wearable insulin device

The agency will help sculpt a campaign aimed at patients with type 2 diabetes who struggle with injections.

Deutsch has been chosen as patient partner agency for Valeritas Holdings’ V-Go -- a wearable insulin delivery device for people with diabetes.

Deutsch will handle all creative, media, and data analytics for the brand’s direct-to-consumer efforts. A fully integrated pilot patient campaign is being planned for roll out in multiple U.S. metropolitan markets in the first half of 2019.  

Valeritas’ President and CEO John Timberlake said: "Deutsch has a proven track record of telling brand stories that emotionally connect with consumers and elevate brands, so they’ll play a critical role in helping us develop a 360-marketing effort that will help empower millions of patients that currently struggle with insulin injections."

The device -- worn like a patch -- is Valeritas’ modern and unique answer for patients with type 2 diabetes.

"We can’t wait to get 2019 started," said the CEO of Deutsch New York, Val DiFebo. "For new clients including Newman’s Own, Lactaid, Constant Contact and now V-Go, we’ll be showcasing a lineup of ambitious creative work designed to drive sales and deepen the brands’ engagement with consumers."

GET YOUR CAMPAIGN DAILY FIX

The latest work, news, advice, comment and analysis, sent to you every day

register free